Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study
Timo VesikariVaccine Research Centre, Medical School, University of Tampere, Tampere, Finland. [email protected]Aino KarvonenVaccine Research Centre, Medical School, University of Tampere, Tampere, FinlandRoman PrymulaFaculty of Military Health Sciences University of Defence, Hradec Králové, Czech RepublicVolker SchusterJC TejedorHospital de Móstoles, Madrid, SpainRobert CohenFrançois MeuriceGlaxoSmithKline#N# Biologicals, Rixensart, BelgiumH.H. HanGlaxoSmithKline#N# Biologicals, Rixensart, BelgiumSilvia DamasoGlaxoSmithKline#N# Biologicals, Rixensart, BelgiumAlain BouckenoogheGlaxoSmithKline#N# Biologicals, Rixensart, Belgium
2007en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба